Cargando…

Immune Persistence and Safety After SARS-CoV-2 BNT162b1 mRNA Vaccination in Chinese Adults: A Randomized, Placebo-Controlled, Double-Blind Phase 1 Trial

INTRODUCTION: BNT162b1 is a lipid nanoparticle-formulated, nucleoside-modified mRNA SARS-CoV-2 vaccine. Here, we report safety and immune persistence data following a primary two-dose vaccination schedule administered 21 days apart. METHODS: Immune persistence was determined at month 3 in 72 younger...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jingxin, Hui, Ai-Min, Zhang, Xiang, Ge, Lei, Qiu, Yuanzheng, Tang, Rong, Ye, Huayue, Wang, Xiyuan, Lin, Mei, Zhu, Zhongkui, Zheng, Jianfei, Qiu, Jingjun, Lagkadinou, Eleni, Shpyro, Svetlana, Ozhelvaci, Orkun, Türeci, Özlem, Khondker, Zakaria, Yin, Wanrong, Shishkova, Yoana, Jia, Siyue, Pan, Hongxing, Peng, Fuzhong, Ma, Zhilong, Wu, Zhenggang, Guo, Xiling, Shi, Yunfeng, Muik, Alexander, Şahin, Uğur, Zhu, Li, Zhu, Fengcai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245386/ https://www.ncbi.nlm.nih.gov/pubmed/35771353 http://dx.doi.org/10.1007/s12325-022-02206-1

Ejemplares similares

Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial
por: Hui, Ai-Min, et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera
por: Muik, Alexander, et al.
Publicado: (2022)

Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5
por: Muik, Alexander, et al.
Publicado: (2022)

Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need
por: Jin, Pengfei, et al.
Publicado: (2021)

Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes
por: Quandt, Jasmin, et al.
Publicado: (2022)

Advances in the progress of monoclonal antibodies for rabies
por: Fan, Linlin, et al.
Publicado: (2022)

Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations
por: Wang, Yang, et al.
Publicado: (2017)

Effects of maternal antibodies in infants on the immunogenicity and safety of inactivated polio vaccine in infants
por: Gao, Shuyu, et al.
Publicado: (2022)

CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2
por: Jin, Lairun, et al.
Publicado: (2022)

Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial
por: Li, Jingxin, et al.
Publicado: (2022)

COVID-19 in children: epidemic issues and candidate vaccines
por: Zhang, Peng, et al.
Publicado: (2022)

A comparison of the test-negative and the matched case-control study designs for estimation of EV71 vaccine immunological surrogate endpoints from a randomized controlled trial
por: Zhang, Li, et al.
Publicado: (2022)

Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial
por: Jin, Pengfei, et al.
Publicado: (2022)

Investigation of the mechanism of Prunella vulgaris in treatment of papillary thyroid carcinoma based on network pharmacology integrated molecular docking and experimental verification
por: Zhu, Xiling, et al.
Publicado: (2023)

Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial
por: Jin, Lairun, et al.
Publicado: (2022)

A broadly neutralizing human monoclonal antibody against the hemagglutinin of avian influenza virus H7N9
por: Li, Jingxin, et al.
Publicado: (2022)

The Research of G–Motif Construction and Chirality in Deoxyguanosine Monophosphate Nucleotide Complexes
por: Zhu, Yanhong, et al.
Publicado: (2021)

Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain
por: Gao, Xingsu, et al.
Publicado: (2022)

Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
por: Pather, Shanti, et al.
Publicado: (2023)

SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
por: Pather, Shanti, et al.
Publicado: (2023)

Identification and classification of papain-like cysteine proteinases
por: Ozhelvaci, Fatih, et al.
Publicado: (2023)

The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
por: McLean, Gary, et al.
Publicado: (2022)

Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice
por: Muik, Alexander, et al.
Publicado: (2022)

Comparative transcriptomic analysis of two Cucumis melo var. saccharinus germplasms differing in fruit physical and chemical characteristics
por: Liang, Renfan, et al.
Publicado: (2022)

Calreticulin Blockade Attenuates Murine Acute Lung Injury by Inducing Polarization of M2 Subtype Macrophages
por: Jiang, Zhilong, et al.
Publicado: (2020)

Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants
por: Zhong, Jiaying, et al.
Publicado: (2022)

Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis
por: Zhang, Xiaoyin, et al.
Publicado: (2023)

A Public Health Perspective on Influenza Status in the Context of COVID-19 Pandemic, 2019−2020
por: Huo, Xiang, et al.
Publicado: (2020)

Could Beta variant containing COVID-19 booster vaccines tackle Omicron variants?
por: Jin, Pengfei, et al.
Publicado: (2023)

Convergence Rates for the Constrained Sampling via Langevin Monte Carlo
por: Zhu, Yuanzheng
Publicado: (2023)

A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults
por: Haranaka, Miwa, et al.
Publicado: (2021)

Comparison of different soft grippers for lunch box packaging
por: Wang, Zhongkui, et al.
Publicado: (2017)

NiH-catalyzed asymmetric hydroarylation of N-acyl enamines to chiral benzylamines
por: He, Yuli, et al.
Publicado: (2021)

1558O COVID-19 vaccine in participants (ptcpts) with cancer: Subgroup analysis of efficacy/safety from a global phase III randomized trial of the BNT162b2 (tozinameran) mRNA vaccine
por: Thomas, S.J., et al.
Publicado: (2021)

Interfacial Solar Steam/Vapor Generation for Heating and Cooling
por: Li, Xiuqiang, et al.
Publicado: (2022)

Integrated analysis of B-cell and T-cell receptors by high-throughput sequencing reveals conserved repertoires in IgA nephropathy
por: Ou, Minglin, et al.
Publicado: (2018)

Plantaricin BM-1 decreases viability of SW480 human colorectal cancer cells by inducing caspase-dependent apoptosis
por: Wang, He, et al.
Publicado: (2023)

Bremsstrahlung spectrum data for thick Al, Ti, Zr, Mo, and W targets by keV electron impact
por: An, Zhu, et al.
Publicado: (2018)

What drives soil degradation after gravel mulching for 6 years in northwest China?
por: Qiu, Yang, et al.
Publicado: (2023)

An Evaluation System of Robotic End-Effectors for Food Handling
por: Qiu, Zhe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9h442i51m7lac0kat5j615rl6i